एपीए उद्धरण

Nakamura, M., Itani, K., Miyake, K., Kunieda, T., Kaneko, S., & Kusaka, H. (2017). Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis. Intern Med.

शिकागो स्टाइल उद्धरण

Nakamura, Masataka, Kumi Itani, Kousuke Miyake, Takenobu Kunieda, Satoshi Kaneko, और Hirofumi Kusaka. "Natalizumab Is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis." Intern Med 2017.

एमएलए उद्धरण

Nakamura, Masataka, et al. "Natalizumab Is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis." Intern Med 2017.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.